Search ResultsKeywords: dronabinol
German cannabis imports growing as Canada’s leading share wanes
Germany imported a record amount of cannabis for medical sales and scientific use in the first half of this year, putting the European Union’s biggest market on pace to match or possibly surpass 2021’s total.
How will inflation impact cannabis retail + two deals that illustrate industry change
While wholesale cannabis prices have been going up – sometimes as much as 30%, according to a recent MJBizDaily story – retail prices for the consumer haven’t been keeping pace.
As competition grows in German medical cannabis flower market, sales strategy becomes key
The growing number of medical cannabis brands and products available to patients in Germany indicates that companies wanting to enter and succeed in that market need to think beyond simply offering a consistent supply of products.
Synthetic cannabinoids linked to increased hospitalizations and deaths in older adults with COPD
A study out of St. Michael’s Hospital in Toronto has found prescription synthetic cannabinoids are linked to a 64% increase in death in older patients with chronic obstructive pulmonary disease (COPD). These oral drugs—nabilone and dronabinol—have a chemical structure similar to THC and are often prescribed to treat symptoms associated with COPD, including pain, sleep difficulties and breathlessness.
Canada exported record amount of dried cannabis in 2019, but mostly to one market
Canadian businesses exported more dried medical cannabis than ever last year, but that growth is expected to be challenged when the country’s main export destination – Germany – initiates local production later this year.